A phase I, 2-part, open label study investigating pharmacokinetics of Belinostat and it's metabolites in patients with advanced solid tumors
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Belinostat (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
Most Recent Events
- 17 Jun 2017 New trial record